Immunic Therapeutics
Oral therapies for the treatment of chronic diseases
![Immunic Therapeutics Logo RGB Immunic Therapeutics Logo](https://www.bmp.com/wp-content/uploads/2022/05/immunic-logo-rgb.svg 1x, https://www.bmp.com/wp-content/uploads/2022/05/immunic-logo-rgb.svg 2x)
About Immunic Therapeutics
Development of small-molecule therapies
The Munich-based biopharmaceutical company develops selective, orally available therapies for the treatment of chronic inflammatory and autoimmune diseases, including multiple sclerosis, ulcerative colitis and Crohn’s disease. The company currently has three small molecule candidates in the development pipeline, which are being tested in various phase 1, 2 and 3 trials worldwide.
Management
bmp Ventures Team
Founded
2016
Invested
2016
Stage
Expansion
Industry
Life Sciences & eHealth
Status
Aktiv